Researchers at Stanford University have formulated a novel biomaterial suitable for three-dimensional (3D) bioprinting: a homogeneous composite of polycaprolactone (PCL), gelatin, and beta-tricalcium phosphate.
Based on their proprietary HyTEC tissue engineering platform, researchers at Stanford have developed an osteoinductive intramedullary implant (IM) device for improved bone healing.
Researchers at Stanford have developed a porous biologics-loaded multimaterial construct, called Hybrid Tissue Engineering Construct (HyTEC), with applications in regenerative medicine and therapeutic delivery.
Stanford inventors have developed a functionally-graded implant device for the reconstitution of the necrotic area removed after surgical treatment of osteonecrosis of the hip.